There is no market for this in China. No med-tech company expects to make money from China currently. Moreover, this provides little real security with respect to Chinese patent law.
To be clear, that does not mean China is not a big market. Just that, currently there is not a big med-tech market. This may yet change but the market knows it will make no impact on near to medium term revenue.
Looks like it found support as the chart predicted. Hope for some consolidation and then, fingers crossed, a another run up. Followed by a pull back, consolidation, run up..........rinse and repeat. I'm hoping we'll see a golden cross sooner or later.
Ann: PharmAust secures core China patent, page-8
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
-0.010(4.26%) |
Mkt cap ! $89.08M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 22.0¢ | $170.5K | 749.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 34313 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 24444 | 2 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
22.5¢ |
Change
-0.010 ( 6.25 %) |
||||
| Open | High | Low | Volume | ||
| 23.0¢ | 23.0¢ | 22.0¢ | 246904 | ||
| Last updated 15.57pm 14/06/2024 ? | |||||
| PAA (ASX) Chart |